ALTSTATION.IO

LyondellBasell Industries N.V. (LYB) Stock Analysis

By Nova Skye | AltStation.io | Updated November 01, 2026

Price
$68.64
Change
+5.00%
Market Cap
$22.19B
Avg Volume
3.7M

Company Overview

LyondellBasell Industries (LYB) is a Rotterdam-based chemical heavyweight operating in the Basic Materials sector under Specialty Chemicals. Incorporated in 2009, the company produces the core building blocks for plastics and industrial materials across 5 distinct operating segments. Their product catalog spans basic olefins and polyolefins like ethylene and polyethylene to intermediate chemicals, oxyfuels, and specialized engineered plastics. They sell directly to manufacturers supplying food packaging, automotive components, home furnishings, and paints and coatings.

LYB operates as an established global scale player rather than a niche producer, running operations across the United States, Germany, China, Mexico, and Europe. Their primary competitive edge comes from proprietary process technology: the Technology segment develops and licenses chemical and polyolefin processes worldwide while selling polyolefin catalysts. The main vulnerability is direct exposure to volatile petrochemical commodity cycles and feedstock pricing in their Olefins and Intermediates divisions. While high-spec compounding solutions and masterbatches offer some buffer, baseline profitability still moves with broad industrial volume.

The company currently balances bulk olefin and polyolefin volume with higher-margin engineered polymer solutions and tech licensing. Operating across 5 segments spanning the Americas, Europe, and Asia, LYB leans on geographic diversification to absorb regional manufacturing slumps. The strategic priority is capturing steady cash from large-scale ethylene and propylene assets while monetizing proprietary technology licensing. For investors, performance tracks directly with end-market demand in automotive, consumer goods, and packaging.

Key Financials
Market Cap
$22.19B
Revenue
$31.19B
EBITDA
$3.57B
Gross Margin
12.9%
Profit Margin
-1.1%
Revenue Growth
19.8%
Total Cash
$2.65B
Total Debt
$14.33B
Free Cash Flow
$1.23B


52-Week Price Performance Analysis

Price Statistics
P/E Ratio
N/A
Forward P/E
10.83
Beta
0.35
52-Week High
$83.94
52-Week Low
$41.58
EPS
$-0.83
50-Day Avg
$62.74
200-Day Avg
$63.84
Price/Book
2.19
LYB 52-Week Stock Chart
Technical Analysis
LYB trades at $68.64, 68% of the way from its $39.12 52-week low to its $82.22 high. The stock is 16.52% below that high but 75.48% above the low. Price sits 8.70% above the 20-day moving average of $63.15. Momentum is positive, with gains of 3.30% over five trading days and 17.17% over 20 trading days. Near-term support is $57.47, while the current price of $68.64 is also the 30-day resistance level.


Recent News and Developments

Q3 profit rebounds as oxyfuels offset polymer pressure

LyondellBasell reported third-quarter net income of $758 million, diluted EPS of $2.32 and adjusted EPS of $2.54. Revenue reached $8.499 billion, up from $7.727 billion a year earlier but down from $9.177 billion in the second quarter. Oxyfuels drove stronger profitability while lower polymer and olefin prices hurt the Americas business. Source: LyondellBasell

Valero buying former Houston refinery site for $320.5 million

LyondellBasell agreed to sell its former Houston refinery site and related assets to a Valero subsidiary for $320.5 million. Valero will assume ongoing operations, environmental liabilities, pension costs and employee obligations. Closing is expected in the fourth quarter, subject to regulatory approval and customary conditions. Source: LyondellBasell

LYB jumps 5% after earnings and refinery deal

LYB closed October 30 at $68.64, up 5.00% on volume of 4,653,474 shares. The stock finished the prior session at $65.37 after falling 2.62%, making Friday’s rebound a clear positive reaction to the company’s earnings and asset-sale announcements. Source: Stock Analysis



Market Sentiment and Analyst Recommendations

Bull Case
Revenue growth of 19.8% gives investors a concrete reason to look past the lack of a reported P/E ratio. Third-quarter revenue rose to $8.499 billion from $7.727 billion a year earlier, while adjusted EPS reached $2.54. Oxyfuels delivered stronger profitability and helped offset weak polymer and olefin pricing. The planned $320.5 million refinery-site sale also transfers ongoing operations, environmental liabilities, pension costs and employee obligations to Valero. The market liked the combined earnings and asset-sale news: LYB gained 5.00% on October 30 and closed at $68.64. With the highest analyst target at $88.00, the upside case is real, but it depends on earnings strength spreading beyond oxyfuels.
Bear Case
LYB carries $14.33 billion of debt against $2.65 billion of cash, leaving a large balance-sheet burden. The missing P/E ratio also removes a basic valuation reference and makes the stock harder to judge on earnings. Third-quarter revenue of $8.499 billion improved from a year earlier but fell from $9.177 billion in the second quarter. Lower polymer and olefin prices hurt the Americas business, showing that core operations remain exposed to commodity pricing. The $67.89 consensus target is below the current $68.64 price, and the recommendation from 18 analysts is hold. The stock is already at its $68.64 30-day high, so buyers are paying near-term resistance while accepting substantial debt and uneven segment performance.
What to Watch
First, track whether the Valero transaction closes in the fourth quarter as expected and whether regulatory approval arrives without complications. The $320.5 million sale matters because Valero is set to assume environmental liabilities, pension costs, employee obligations and ongoing operations tied to the site. Watch whether quarterly revenue can recover from $8.499 billion toward the previous quarter’s $9.177 billion. Investors also need evidence that polymer and olefin pricing is improving rather than leaving oxyfuels to carry profitability. On the chart, a move above $68.64 would break the current 30-day resistance level, while a decline toward $63.15 would erase the stock’s 8.70% premium to its 20-day average. A drop toward $57.47 would weaken the near-term trend, while sustained momentum above the current range would strengthen the bull case.
Analyst Consensus
HOLD

Based on 18 analyst opinions
Low Target
$56.00
Mean Target
$67.89
High Target
$88.00


Earnings and Financial Data

Sector
Basic Materials
Industry
Specialty Chemicals
Employees
18,970
Earnings & Dividends
Next Earnings
Jan 29, 2027
EPS (Trailing)
$-0.83
Dividend Yield
402.0%
Payout Ratio
748.6%

Frequently Asked Questions

Is LYB a good stock to buy?
LYB has 19.8% revenue growth, but the consensus recommendation from 18 analysts is hold. At $68.64, the stock also trades above the $67.89 average analyst target, so the current data supports patience rather than an aggressive buy.
What is LYB’s price target?
The average analyst target is $67.89, with estimates ranging from $56.00 to $88.00. The current $68.64 price is above the consensus target, so analysts collectively see limited upside at this level.
Is LYB stock overvalued?
A P/E ratio is not available, so the provided data does not support a definitive earnings-based valuation. The stock trades above the $67.89 average analyst target, making it look fully valued by that measure.
What are LYB’s support and resistance levels?
Near-term support is the 30-day low of $57.47, and near-term resistance is the 30-day high of $68.64. Because the stock currently trades at $68.64, it is testing resistance now.
How strong is LYB’s momentum?
LYB gained 3.30% over the last five trading days and 17.17% over the last 20 trading days. The price is also 8.70% above its $63.15 20-day moving average, so near-term momentum is clearly positive.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated November 01, 2026.